The dark side of immunotherapy

Immunotherapy has broadened the therapeutic scope and response for many cancer patients with drugs that are generally of higher efficacy and less toxicity than prior therapies. Multiple classes of immunotherapies such as targeted antibodies and immune checkpoint inhibitors (ICI), cell-based immunoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Okwundu, Nwanneka, Grossman, Douglas, Hu-Lieskovan, Siwen, Grossmann, Kenneth F., Swami, Umang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Cancer Immunotherapy: Recent Advances and Challenges
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267325/
https://www.ncbi.nlm.nih.gov/pubmed/34277841
http://dx.doi.org/10.21037/atm-20-4750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267325/
https://www.ncbi.nlm.nih.gov/pubmed/34277841
http://dx.doi.org/10.21037/atm-20-4750

Ejemplares similares